Correction: Chavda et al. Peptide-Drug Conjugates: A New Hope for Cancer Management. Molecules 2022, 27, 7232

Affiliations

¹ Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380008, Gujarat, India.
² Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
³ Immunology Program, Australian Institute for Musculoskeletal Science, Melbourne, VIC 3021, Australia.
⁴ Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, 116 Zeromskiego Street, 90-924 Lodz, Poland.

Published Erratum

Vivek P Chavda et al. Molecules. 2025.

. 2025 Jun 13;30(12):2579.

doi: 10.3390/molecules30122579.

¹ Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380008, Gujarat, India.
² Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
³ Immunology Program, Australian Institute for Musculoskeletal Science, Melbourne, VIC 3021, Australia.
⁴ Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, 116 Zeromskiego Street, 90-924 Lodz, Poland.

Abstract

In the original publication cited above [...].

Peptide-Drug Conjugates: A New Hope for Cancer Management.
Chavda VP, Solanki HK, Davidson M, Apostolopoulos V, Bojarska J. Chavda VP, et al. Molecules. 2022 Oct 25;27(21):7232. doi: 10.3390/molecules27217232. Molecules. 2022. PMID: 36364057 Free PMC article. Review.

1. Chavda V.P., Solanki H.K., Davidson M., Apostolopoulos V., Bojarska J. Peptide-Drug Conjugates: A New Hope for Cancer Management. Molecules. 2022;27:7232. doi: 10.3390/molecules27217232. - DOI - PMC - PubMed